Ellen H. M. Moors - Search Results

Year	Number of Results
2007	1
2011	2
2012	4
2013	4
2014	2
2015	1
2019	3
2020	5
2021	7
2022	1

1

Market Formation in a Global Health Transition.

de Haan F, Moors EHM, Dondorp AM, Boon WPC. de Haan F, et al. Among authors: moors ehm. Environ Innov Soc Transit. 2021 Sep;40:40-59. doi: 10.1016/j.eist.2021.05.003. Environ Innov Soc Transit. 2021. PMID: 35106274 Free PMC article.

2

¹⁷⁷Lu-PSMA for advanced prostate cancer: are we ready to play big?

Hehakaya C, Moors EHM, Verkooijen HM, Grobbee DE, Verburg FA, Lam MGEH. Hehakaya C, et al. Among authors: moors ehm. Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2325-2328. doi: 10.1007/s00259-020-05102-4. Eur J Nucl Med Mol Imaging. 2021. PMID: 33161440 No abstract available.

3

Towards a sustainable system of drug development.

Moors EHM, Cohen AF, Schellekens H. Moors EHM, et al. Drug Discov Today. 2014 Nov;19(11):1711-1720. doi: 10.1016/j.drudis.2014.03.004. Epub 2014 Mar 19. Drug Discov Today. 2014. PMID: 24657626 Review.

4

Levelling the Translational Gap for Animal to Human Efficacy Data.

Ferreira GS, Veening-Griffioen DH, Boon WPC, Moors EHM, van Meer PJK. Ferreira GS, et al. Among authors: moors ehm. Animals (Basel). 2020 Jul 15;10(7):1199. doi: 10.3390/ani10071199. Animals (Basel). 2020. PMID: 32679706 Free PMC article. Review.

5

Measures of biosimilarity in monoclonal antibodies in oncology: the case of bevacizumab.

Ebbers HC, van Meer PJ, Moors EH, Mantel-Teeuwisse AK, Leufkens HG, Schellekens H. Ebbers HC, et al. Among authors: moors eh. Drug Discov Today. 2013 Sep;18(17-18):872-9. doi: 10.1016/j.drudis.2013.05.004. Epub 2013 May 18. Drug Discov Today. 2013. PMID: 23688584 Review.

6

Today's challenges in pharmacovigilance: what can we learn from epoetins?

Ebbers HC, Mantel-Teeuwisse AK, Moors EH, Schellekens H, Leufkens HG. Ebbers HC, et al. Among authors: moors eh. Drug Saf. 2011 Apr 1;34(4):273-87. doi: 10.2165/11586350-000000000-00000. Drug Saf. 2011. PMID: 21417500 Review.

7

Contribution of animal studies to evaluate the similarity of biosimilars to reference products.

van Meer PJ, Ebbers HC, Kooijman M, Gispen-de Wied CC, Silva-Lima B, Moors EH, Schellekens H. van Meer PJ, et al. Among authors: moors eh. Drug Discov Today. 2015 Apr;20(4):483-90. doi: 10.1016/j.drudis.2014.11.009. Epub 2014 Nov 20. Drug Discov Today. 2015. PMID: 25463036 Review.

8

From Mattering to Mattering More: 'Goods' and 'Bads' in Ageing and Innovation Policy Discourses.

Greubel C, Moors EHM, Peine A. Greubel C, et al. Among authors: moors ehm. Int J Environ Res Public Health. 2021 Jul 16;18(14):7596. doi: 10.3390/ijerph18147596. Int J Environ Res Public Health. 2021. PMID: 34300047 Free PMC article.

9

Tradition, not science, is the basis of animal model selection in translational and applied research.

Veening-Griffioen DH, Ferreira GS, Boon WPC, Gispen-de Wied CC, Schellekens H, Moors EHM, Van Meer PJK. Veening-Griffioen DH, et al. Among authors: moors ehm. ALTEX. 2021;38(1):49-62. doi: 10.14573/altex.2003301. Epub 2020 Jun 22. ALTEX. 2021. PMID: 32591838 Free article.

10

Towards Responsible Artificial Intelligence in Long-term Care: A Scoping Review on Practical Approaches.

Lukkien DRM, Nap HH, Buimer HP, Peine A, Boon WPC, Ket JCF, Minkman MMN, Moors EHM. Lukkien DRM, et al. Among authors: moors ehm. Gerontologist. 2021 Dec 6:gnab180. doi: 10.1093/geront/gnab180. Online ahead of print. Gerontologist. 2021. PMID: 34871399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results